CBS 2019
CBSMD教育中心
中 文

News

Abstract

Recommended Article

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients FDA Rejects Canakinumab in CVD Prevention China’s PADN Procedure Presented at CHIP INDIA SUMMIT, Opening a New Chapter in Pulmonary Arterial Hypertension Treatment Multiple PADN Case Studies – Nanjing First Hospital Cardiovascular Department Pakistan Live 2025 – Nanjing First Hospital Team Demonstrates a Complex Left Main Bifurcation Intervention

PerspectiveVolume 76, Issue 13, September 2020

JOURNAL:J Am Coll Cardiol. Article Link

Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives

DE Forman, JA de Lemos, and for the Geriatric Cardiology Section Leadership Council. Keywords: aging; biomarkers; cardiovascular testing; imaging; shared decision making; stress testing

ABSTRACT

Whereas the burgeoning population of older adults is intrinsically vulnerable to cardiovascular disease, the utility of many management precepts that were validated in younger adults is often unclear. Whereas biomarker- and imaging-based tests are a major part of cardiovascular disease care, basic assumptions about their use and efficacy cannot be simply extrapolated to many older adults. Biology, physiology, and body composition change with aging, with important influences on cardiovascular disease testing procedures and their interpretation. Furthermore, clinical priorities of older adults are more heterogeneous, potentially undercutting the utility of testing data that are collected. The American College of Cardiology and the National Institutes on Aging, in collaboration with the American Geriatrics Society, convened, at the American College of Cardiology Heart House, a 2-day multidisciplinary workshop, “Diagnostic Testing in Older Adults with Cardiovascular Disease,” to address these issues. This review summarizes key concepts, clinical limitations, and important opportunities for research.